MATN1 and atrial fibrillation: To assess the influence of these factors on increased cMP, PMP, and EMP (CD31+ CD41−) levels in AF patients, we evaluated each of these parameters in AF patients compared between the presence or absence of each cardiovascular risk factor and antithrombotic drugs.